Epidemiology: Global Burden of Disease Study 2013 reports that disability caused by CKD is increasing worldwide.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.The Journal of international medical research · 2017
   Pooled it
2. Chronic Kidney Disease Burden Attributable to Metabolic Risks Among Women Aged ≥55 Years Worldwide, 1990-2021: A Global Burden of Disease Study 2021 Analysis.Risk management and healthcare policy · 2026
   Article
3. Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021.Frontiers in public health · 2025
   Article
4. Predictors of functional status and disability among patients living with chronic kidney diseases at St Paul's hospital millennium medical college, Ethiopia: findings from a cross-sectional study.BMC nephrology · 2024
   Article
5. Prevalence of medication adherence among adult asthmatic patients in four African countries: A systematic review and meta-analysis.The World Allergy Organization journal · 2024
   Review
6. Nonadherence to antiasthmatic medications and its predictors among asthmatic patients in public hospitals of Bahir Dar City, North West Ethiopia: using ASK-12 tool.Asthma research and practice · 2023
   Article
7. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study.BMJ open · 2019
   Article
8. Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin-induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway.Experimental and therapeutic medicine · 2018
   Article
9. The Association of Daily Activity Levels and Estimated Kidney Function in Men and Women With Predialysis Chronic Kidney Disease.Kidney international reports · 2017
   Article
10. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Nature reviews. Nephrology · 2017
    Review
11. Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review.PloS one · 2017
    Review

Corrections and comments

• Comment on
  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.2015

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as